Fralex Therapeutics Inc. , a medical technology company developing neuromodulation therapy, today announced the initiation of RELIEF, its pivotal study for the treatment of chronic pain associated with fibromyalgia.
From: biz.yahoo.com
Thursday, March 22, 2007
Fralex Therapeutics Inc. initiates pivotal trial for chronic pain associated with fibromyalgia
Subscribe to:
Post Comments (Atom)
![Digitalpoint Geo Tracking [Enabled]](http://geo.digitalpoint.com/a.png)
![PingOmatic AutoDiscovery [Enabled]](http://www.genuineblogger.com/images/chicklet-pingomatic.gif)
![Made with Palestinian Efforts [True]](http://www.genuineblogger.com/images/yapalestinets.gif)
No comments:
Post a Comment